Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Country/Region, 2017, 2022 & 2028

2.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Segment by Type

2.2.1 Live Vaccine

2.2.2 Inactivated Vaccine

2.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type

2.3.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2017-2022)

2.3.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue and Market Share by Type (2017-2022)

2.3.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sale Price by Type (2017-2022)

2.4 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Segment by Application

2.4.1 Government Tender

2.4.2 Marketing

2.5 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application

2.5.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sale Market Share by Application (2017-2022)

2.5.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue and Market Share by Application (2017-2022)

2.5.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sale Price by Application (2017-2022)

3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Company

3.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Breakdown Data by Company

3.1.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Annual Sales by Company (2020-2022)

3.1.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Company (2020-2022)

3.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Annual Revenue by Company (2020-2022)

3.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Company (2020-2022)

3.2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Company (2020-2022)

3.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sale Price by Company

3.4 Key Manufacturers Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Location Distribution

3.4.2 Players Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Geographic Region

4.1 World Historic Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Geographic Region (2017-2022)

4.1.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Annual Revenue by Geographic Region

4.2 World Historic Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country/Region (2017-2022)

4.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Annual Sales by Country/Region (2017-2022)

4.2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Annual Revenue by Country/Region

4.3 Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Growth

4.4 APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Growth

4.5 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Growth

4.6 Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Growth

5 Americas

5.1 Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country

5.1.1 Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2017-2022)

5.1.2 Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2017-2022)

5.2 Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type

5.3 Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region

6.1.1 APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2017-2022)

6.1.2 APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region (2017-2022)

6.2 APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type

6.3 APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Country

7.1.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2017-2022)

7.1.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2017-2022)

7.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type

7.3 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Country

8.1.1 Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2017-2022)

8.1.2 Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2017-2022)

8.2 Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type

8.3 Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)

10.3 Manufacturing Process Analysis of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)

10.4 Industry Chain Structure of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Distributors

11.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Customer

12 World Forecast Review for Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Geographic Region

12.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Forecast by Region

12.1.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Forecast by Region (2023-2028)

12.1.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Forecast by Type

12.7 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Forecast by Application

13 Key Players Analysis

13.1 CNADC

13.1.1 CNADC Company Information

13.1.2 CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

13.1.3 CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 CNADC Main Business Overview

13.1.5 CNADC Latest Developments

13.2 Boehringer-Ingelheim

13.2.1 Boehringer-Ingelheim Company Information

13.2.2 Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

13.2.3 Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Boehringer-Ingelheim Main Business Overview

13.2.5 Boehringer-Ingelheim Latest Developments

13.3 MSD Animal Health

13.3.1 MSD Animal Health Company Information

13.3.2 MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

13.3.3 MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 MSD Animal Health Main Business Overview

13.3.5 MSD Animal Health Latest Developments

13.4 Sinopharm

13.4.1 Sinopharm Company Information

13.4.2 Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

13.4.3 Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Sinopharm Main Business Overview

13.4.5 Sinopharm Latest Developments

13.5 Ceva

13.5.1 Ceva Company Information

13.5.2 Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

13.5.3 Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Ceva Main Business Overview

13.5.5 Ceva Latest Developments

13.6 Chengdu Tianbang Biological Products Co., Ltd.

13.6.1 Chengdu Tianbang Biological Products Co., Ltd. Company Information

13.6.2 Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

13.6.3 Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Chengdu Tianbang Biological Products Co., Ltd. Main Business Overview

13.6.5 Chengdu Tianbang Biological Products Co., Ltd. Latest Developments

13.7 Tianjin Ruipu Biological Technology Co., Ltd.

13.7.1 Tianjin Ruipu Biological Technology Co., Ltd. Company Information

13.7.2 Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

13.7.3 Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Tianjin Ruipu Biological Technology Co., Ltd. Main Business Overview

13.7.5 Tianjin Ruipu Biological Technology Co., Ltd. Latest Developments

13.8 Qilu Animal Health

13.8.1 Qilu Animal Health Company Information

13.8.2 Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

13.8.3 Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Qilu Animal Health Main Business Overview

13.8.5 Qilu Animal Health Latest Developments

13.9 Guangdong Wens Dahuanong Biotechnology Co., Ltd.

13.9.1 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Company Information

13.9.2 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

13.9.3 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Main Business Overview

13.9.5 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Latest Developments

13.10 CAVAC

13.10.1 CAVAC Company Information

13.10.2 CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

13.10.3 CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 CAVAC Main Business Overview

13.10.5 CAVAC Latest Developments

13.11 Komipharm

13.11.1 Komipharm Company Information

13.11.2 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

13.11.3 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Komipharm Main Business Overview

13.11.5 Komipharm Latest Developments

13.12 Agrovet

13.12.1 Agrovet Company Information

13.12.2 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

13.12.3 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Agrovet Main Business Overview

13.12.5 Agrovet Latest Developments

13.13 Bioveta

13.13.1 Bioveta Company Information

13.13.2 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

13.13.3 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Bioveta Main Business Overview

13.13.5 Bioveta Latest Developments

13.14 Jinyu Bio-Technology

13.14.1 Jinyu Bio-Technology Company Information

13.14.2 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

13.14.3 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Jinyu Bio-Technology Main Business Overview

13.14.5 Jinyu Bio-Technology Latest Developments

13.15 Phibro Animal Health

13.15.1 Phibro Animal Health Company Information

13.15.2 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

13.15.3 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Phibro Animal Health Main Business Overview

13.15.5 Phibro Animal Health Latest Developments

13.16 Tiankang

13.16.1 Tiankang Company Information

13.16.2 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

13.16.3 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Tiankang Main Business Overview

13.16.5 Tiankang Latest Developments

13.17 Zoetis

13.17.1 Zoetis Company Information

13.17.2 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

13.17.3 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Zoetis Main Business Overview

13.17.5 Zoetis Latest Developments

13.18 Guangdong Yongshun Biological Pharmaceutical Co Ltd

13.18.1 Guangdong Yongshun Biological Pharmaceutical Co Ltd Company Information

13.18.2 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

13.18.3 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Guangdong Yongshun Biological Pharmaceutical Co Ltd Main Business Overview

13.18.5 Guangdong Yongshun Biological Pharmaceutical Co Ltd Latest Developments

13.19 Plec Bioengineering Co., Ltd.

13.19.1 Plec Bioengineering Co., Ltd. Company Information

13.19.2 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

13.19.3 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Plec Bioengineering Co., Ltd. Main Business Overview

13.19.5 Plec Bioengineering Co., Ltd. Latest Developments

14 Research Findings and Conclusion

Table 1. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Live Vaccine

Table 4. Major Players of Inactivated Vaccine

Table 5. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2017-2022) & (K Units)

Table 6. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2017-2022)

Table 7. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2017-2022) & ($ million)

Table 8. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Type (2017-2022)

Table 9. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2017-2022) & (K Units)

Table 11. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2017-2022)

Table 12. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2017-2022)

Table 13. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Application (2017-2022)

Table 14. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Company (2020-2022) & (K Units)

Table 16. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Company (2020-2022)

Table 17. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Company (2020-2022)

Table 19. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Producing Area Distribution and Sales Area

Table 21. Players Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered

Table 22. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share Geographic Region (2017-2022)

Table 27. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country/Region (2017-2022)

Table 31. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2017-2022) & (K Units)

Table 34. Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country (2017-2022)

Table 35. Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country (2017-2022)

Table 37. Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2017-2022) & (K Units)

Table 38. Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2017-2022)

Table 39. Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2017-2022) & (K Units)

Table 40. Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2017-2022)

Table 41. APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2017-2022) & (K Units)

Table 42. APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Region (2017-2022)

Table 43. APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Region (2017-2022)

Table 45. APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2017-2022) & (K Units)

Table 46. APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2017-2022)

Table 47. APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2017-2022) & (K Units)

Table 48. APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2017-2022)

Table 49. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2017-2022) & (K Units)

Table 50. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country (2017-2022)

Table 51. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country (2017-2022)

Table 53. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2017-2022) & (K Units)

Table 54. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2017-2022)

Table 55. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2017-2022) & (K Units)

Table 56. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)

Table 66. Key Market Challenges & Risks of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)

Table 67. Key Industry Trends of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)

Table 68. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Distributors List

Table 71. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Customer List

Table 72. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Forecast by Region

Table 74. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share Forecast by Application (2023-2028)

Table 92. CNADC Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors

Table 93. CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

Table 94. CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. CNADC Main Business

Table 96. CNADC Latest Developments

Table 97. Boehringer-Ingelheim Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors

Table 98. Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

Table 99. Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Boehringer-Ingelheim Main Business

Table 101. Boehringer-Ingelheim Latest Developments

Table 102. MSD Animal Health Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors

Table 103. MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

Table 104. MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. MSD Animal Health Main Business

Table 106. MSD Animal Health Latest Developments

Table 107. Sinopharm Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors

Table 108. Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

Table 109. Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Sinopharm Main Business

Table 111. Sinopharm Latest Developments

Table 112. Ceva Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors

Table 113. Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

Table 114. Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Ceva Main Business

Table 116. Ceva Latest Developments

Table 117. Chengdu Tianbang Biological Products Co., Ltd. Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors

Table 118. Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

Table 119. Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. Chengdu Tianbang Biological Products Co., Ltd. Main Business

Table 121. Chengdu Tianbang Biological Products Co., Ltd. Latest Developments

Table 122. Tianjin Ruipu Biological Technology Co., Ltd. Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors

Table 123. Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

Table 124. Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Tianjin Ruipu Biological Technology Co., Ltd. Main Business

Table 126. Tianjin Ruipu Biological Technology Co., Ltd. Latest Developments

Table 127. Qilu Animal Health Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors

Table 128. Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

Table 129. Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Qilu Animal Health Main Business

Table 131. Qilu Animal Health Latest Developments

Table 132. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors

Table 133. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

Table 134. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Main Business

Table 136. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Latest Developments

Table 137. CAVAC Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors

Table 138. CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

Table 139. CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 140. CAVAC Main Business

Table 141. CAVAC Latest Developments

Table 142. Komipharm Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors

Table 143. Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

Table 144. Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 145. Komipharm Main Business

Table 146. Komipharm Latest Developments

Table 147. Agrovet Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors

Table 148. Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

Table 149. Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 150. Agrovet Main Business

Table 151. Agrovet Latest Developments

Table 152. Bioveta Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors

Table 153. Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

Table 154. Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 155. Bioveta Main Business

Table 156. Bioveta Latest Developments

Table 157. Jinyu Bio-Technology Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors

Table 158. Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

Table 159. Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 160. Jinyu Bio-Technology Main Business

Table 161. Jinyu Bio-Technology Latest Developments

Table 162. Phibro Animal Health Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors

Table 163. Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

Table 164. Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 165. Phibro Animal Health Main Business

Table 166. Phibro Animal Health Latest Developments

Table 167. Tiankang Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors

Table 168. Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

Table 169. Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 170. Tiankang Main Business

Table 171. Tiankang Latest Developments

Table 172. Zoetis Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors

Table 173. Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

Table 174. Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 175. Zoetis Main Business

Table 176. Zoetis Latest Developments

Table 177. Guangdong Yongshun Biological Pharmaceutical Co Ltd Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors

Table 178. Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

Table 179. Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 180. Guangdong Yongshun Biological Pharmaceutical Co Ltd Main Business

Table 181. Guangdong Yongshun Biological Pharmaceutical Co Ltd Latest Developments

Table 182. Plec Bioengineering Co., Ltd. Basic Information, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base, Sales Area and Its Competitors

Table 183. Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered

Table 184. Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 185. Plec Bioengineering Co., Ltd. Main Business

Table 186. Plec Bioengineering Co., Ltd. Latest Developments

List of Figures

Figure 1. Picture of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)

Figure 2. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Live Vaccine

Figure 10. Product Picture of Inactivated Vaccine

Figure 11. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type in 2021

Figure 12. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Type (2017-2022)

Figure 13. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Consumed in Government Tender

Figure 14. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market: Government Tender (2017-2022) & (K Units)

Figure 15. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Consumed in Marketing

Figure 16. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market: Marketing (2017-2022) & (K Units)

Figure 17. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2017-2022)

Figure 18. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Application in 2021

Figure 19. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Company in 2021

Figure 21. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Geographic Region in 2021

Figure 23. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Region (2017-2022)

Figure 24. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country/Region in 2021

Figure 25. Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales 2017-2022 (K Units)

Figure 26. Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue 2017-2022 ($ Millions)

Figure 27. APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales 2017-2022 (K Units)

Figure 28. APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue 2017-2022 ($ Millions)

Figure 29. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales 2017-2022 (K Units)

Figure 30. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue 2017-2022 ($ Millions)

Figure 33. Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country in 2021

Figure 34. Americas Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country in 2021

Figure 35. United States Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Region in 2021

Figure 40. APAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Regions in 2021

Figure 41. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country in 2021

Figure 48. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country in 2021

Figure 49. Germany Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country in 2021

Figure 56. Egypt Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) in 2021

Figure 62. Manufacturing Process Analysis of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)

Figure 63. Industry Chain Structure of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles